Therapeutic and Epigenetic Effects of Bee Venom on Acute Toxoplasmosis in Mice: A Parasitological, Histopathological, and MicroRNA Analysis
Authors: Moubarak, Mai A; Abdelmaksoud, Hagar F; Shaker, Maysa H; Zalat, Rabab S; Hassan, Marwa; ElSherbini, Mona S; Ismail, Mousa A M
Source journal: Acta parasitologica (2026-11-18)
DOI: 10.1007/s11686-026-01426-7
Abstract
Acute toxoplasmosis can cause severe complications, while available treatments may be associated with adverse effects. Bee venom (BV) has potential antiparasitic and immunomodulatory properties; however, its therapeutic effects against acute toxoplasmosis, particularly in combination with spiramycin (SPI), remain insufficiently investigated. This study evaluated the effects of BV alone and in combination with SPI on parasitic burden, histopathological alterations, and serum microRNA expression in experimental acute toxoplasmosis. Acute toxoplasmosis was induced in Swiss albino mice using the virulent RH strain of Toxoplasma gondii. Infected mice received different BV and/or SPI treatment regimens. Therapeutic efficacy was assessed by determining tachyzoite counts in peritoneal fluid, examining liver and lung histopathology, and measuring serum expression of mmu-miR-712-3p and mmu-miR-146b-5p using real-time PCR. The different treatment regimens demonstrated varying degrees of therapeutic efficacy, with the combined BV + SPI regimen producing the greatest reduction in tachyzoite counts (96%) compared with untreated infected mice. Infection was associated with 24.47-fold and 83.64-fold increases in mmu-miR-712-3p and mmu-miR-146b-5p expression, respectively. Treatment significantly reduced the expression of these microRNAs, with the greatest reduction observed following combined therapy. Histopathological examination revealed improvements in hepatic and pulmonary lesions following treatment, with the most pronounced amelioration observed in the BV + SPI group. These findings suggest that BV has promising therapeutic potential against acute experimental toxoplasmosis, both alone and in combination with SPI. The observed changes in mmu-miR-712-3p and mmu-miR-146b-5p expression warrant further investigation to clarify their roles in the host response to infection and their potential value as indicators of treatment response.
Related topics
Related open access articles
- MicroRNA-20a-3p and microRNA-20a-5p exhibit anti-proliferative activities in a melanoma in vitro model
- microRNA expression profiling in human diploid cells infected with enterovirus 71 or coxsackievirus A16
- Effects of ATRA on proliferation, migration and cell cycle of gastric cancer MGC-803 cells
- Caveolin-1 inhibits proliferation and migration of gastric cancer cell via inactivating BMI-1
- Expression of Oct4 and RhoA in gastric cancer and their correlation with clinicopathological characteristics
- Effects of Black Vinegar and Niacinamide on LPS-Induced Inflammation on Human Keratinocytes
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.